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Abstract
 
We investigated the mechanism of CD4 T cell accumulation in B cell follicles after immuniza-
tion. Follicular T cell numbers were correlated with the number of B cells, indicating B cell
control of the niche that T cells occupy. Despite this, we found no role for B cells in the fol-
licular migration of T cells. Instead, T cells are induced to migrate into B cell follicles entirely
as a result of interaction with dendritic cells (DCs). Migration relies on CD40-dependent mat-
uration of DCs, as it did not occur in CD40-deficient mice but was reconstituted with CD40
 
 
 
DCs. Restoration was not achieved by the activation of DCs with bacterial activators (e.g., li-
popolysaccharide, CpG), but was by the injection of OX40L–huIgG1 fusion protein. Cru-
cially, the up-regulation of OX40L (on antigen-presenting cells) and CXCR-5 (on T cells) are
CD40-dependent events and we show that T cells do not migrate to follicles in immunized
OX40-deficient mice.
Key words: T lymphocyte migration • B lymphocytes • OX40 • CXCR5 • lymphoid follicles
 
Introduction
 
T-dependent humoral immune responses are characterized
by the development of germinal centers (GCs)
 
*
 
 in B cell
follicles of the secondary lymphoid organs, the formation of
immunological memory, and long-term production of spe-
cific antibodies by bone marrow (BM) plasma cells. Both
memory B cells and long-lived plasma cells are generated in
GCs. T cells provide help to initiate the GC, maintain B
cell proliferation, cause differentiation within the GC, and
finally deliver long-term survival signals (via CD40) that
allow GC B cells to enter the memory pool. These events
require the presence of T cells inside or close to B cell folli-
cles. T cells located in the follicle have long been recog-
nized and are thought to be antigen specific (1). These T
cells are heterogeneous in phenotype and apparent func-
tion. Those located around the GC edge contain pre-
formed CD40L rapidly expressed after TCR activation (2)
and are likely to direct GC B cells into the memory pool.
On the other hand, T cells inside the GC of human tonsils
display a unique cytokine profile that seems to enhance
their capacity to help B cell antibody production (3–5).
Many of these T cells can be identified by the markers
CXCR-5
 
  
 
CD57
 
  
 
CCR7
 
  
 
and are proposed as a new,
specialized subset of Th cells called “follicular helper T
cells” (3–5), which is neither Th1 nor Th2.
Some of the naive T cells first activated in T zones by
peptide antigen presented by dendritic cells (DCs; refer-
ence 6), as a secondary event engage in cognate interaction
with antigen-specific B cells, either in the T zones (7, 8) or
after migration to the border of the follicle (9). After this
T–B interaction, some of the B cells enter follicles to ini-
tiate GCs and a subset of the activated Th cells migrate
with them. The activation-induced events that control T
cell migration to the B cell follicles are not well under-
stood. Roles for the costimulatory molecule OX40L
and the chemokine receptor CXCR-5 have been pro-
posed. CXCR-5 confers responsiveness to B lymphocyte
chemokine (BLC; CXCL13), which is produced by follic-
ular stroma cells (10, 11). CXCR-5 is constitutively ex-
pressed by recirculating B cells and is required for their mi-
gration into B cell follicles (12). It is also induced on T cells
after antigenic stimulation (13) and most follicular T cells
seem to express CXCR-5. T cells stimulated in the
presence of OX40L transfectants up-regulate CXCR-5
transcription (14) and transgenic mice, expressing large
amounts of OX40L on DCs, display an increased number
of T cells in B cell follicles (15). In addition, human T cells
were recently shown to up-regulate CXCR-5 after activa-
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 BLC, B lymphocyte chemokine; BM,
bone marrow; DC, dendritic cell; ELC, Epstein Barr virus–induced mol-
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tion by DCs (16). However, CXCR-5 expression does not
strictly correlate with T cell migration in B cell follicles.
Upon transfer, purified CXCR-5
 
  
 
T cells do not migrate
to the B cell follicles (13) and after immune challenge a
large proportion of CXCR-5
 
  
 
T cells accumulate at the
border between the T zone and the follicles, but do not en-
ter (3, 5). These observations show that CXCR-5 expres-
sion alone is not sufficient for follicular localization and that
ancillary factors are required.
Despite the data discussed above there is no direct evi-
dence that interaction with DCs under normal circum-
stances in vivo controls migration of T cells to follicles. In
fact, the selectivity of the process (only a fraction of T cells
enter follicles) suggests that DCs, as the primary APCs that
activate all naive T cells, are unlikely to be solely responsi-
ble for this migration. Indeed, several observations point to
activated B cells as regulators of T cell migration to folli-
cles. First, CXCR-5–expressing T cells accumulate at the
follicular border after transfer (13), a place where B and T
cells engage in cognate interaction (9). Second, we showed
previously that the generation of T cell help for antibody
production depends upon antigen presentation by B cells
(17). Third, activated B cells are known to produce che-
motactic factors acting selectively on primed T cells, e.g.,
IL-16 (18), macrophage inflammatory protein (MIP)-1
 
 
 
,
MIP-1
 
 
 
 (19), ABCD-1, ABCD-2 (20), and fractalkine
(21). Finally, B cell control could explain the selectivity of
the migration. T cells in contact with DCs would only mi-
grate to inflammatory sites whereas those interacting with
B cells would be induced to migrate to follicles. The in-
volvement of B cells in this process has not yet been inves-
tigated and therefore we set out to analyze the respective
roles of DCs and B cells. Our starting point in these studies
was our observation that T cell migration to follicles is
CD40 dependent as it was absent in CD40-deficient mice.
To investigate further we used a number of novel BM chi-
mera models to restrict expression of genes of interest to
defined cell populations within lymphoid tissues.
 
Materials and Methods
 
Mice and Immunizations.
 
C57BL6, CD40
 
    
 
(22), CD40L
 
   
 
(23), A
 
 
 
    
 
(24), MD4-RAG (25), OT-II (26), and 
 
 
 
MT (27)
mice were bred and maintained in the Science Faculty Animal
Facility at the University of Edinburgh under specific pathogen-
free conditions. All mice were backcrossed onto the C57Bl/6
background between five (A
 
 
 
   
 
) and seven (CD40
 
   
 
) genera-
tions. OX40-deficient mice (28) were provided by M. Kopf,
Swiss Federal Institute of Technology Zürich, Zürich, Switzer-
land, and immunized in his lab. Immunizations involved injec-
tion of 100 
 
 
 
g alum-precipitated antigen (see below) intraperi-
toneally. 200 
 
 
 
g stimulating anti-CD40 (FGK-45) antibody was
injected 6 h after immunization. B7.1–huIgG1 and OX40L–
huIgG1 fusion proteins were injected intravenously at a dose of
200 
 
 
 
g daily from days 1 to 5 after immunization. 10 
 
 
 
g LPS, 10
 
 
 
g CpG (5
 
 
 
-TCCATGACGTTCCTGATGCT-3
 
 
 
), and 10 
 
 
 
g
non-CpG (5
 
 
 
-TCCATGAGCTTCCTGATGCT-3
 
 
 
) phosphor-
othioates oligonucleotides (MWG Biotech) and 2 
 
  
 
10
 
9 
 
chemi-
cally killed 
 
Bordetella pertussis
 
 (Calbiochem-Novabiochem) were
 
all injected intraperitoneally at the same time as antigen. Anti-
gens used for immunization were KLH (Calbiochem-Novabio-
chem), DNP-KLH, or DNP-OVA, prepared as previously de-
scribed (29).
 
Antibodies and Fusion Proteins.
 
Monoclonal antibodies to
Thy1 (T24) and IA
 
d 
 
(MK-D6) were originally obtained from the
American Type Culture Collection (ATCC). Monoclonal anti-
bodies AF6-120.1 (anti-IA
 
b
 
), HL3 (anti-CD11c), RM134L (anti-
OX40L), and biotin-labeled MR9-4 (anti-V
 
 
 
5) were all pur-
chased from BD Biosciences. Ly-2 (anti-CD8a) was purchased
from Caltag. Sheep anti–mouse IgD was purchased from The
Binding Site. Anti-CD40, FGK-45 (30), was provided by A.
Rolink, Basel Institute for Immunology, Basel, Switzerland.
B7.1–huIgG1 fusion protein was provided by P. Lane, University
of Birmingham, Birmingham, United Kingdom, and the
OX40L–huIgG1 was provided by Cantab Pharmaceuticals Re-
search Ltd. (31). The antibody to mouse CXCR5 (clone 2G8)
was provided by M. Lipp, Max Delbrück Center for Molecular
Medicine, Berlin, Germany.
 
BM Chimeras.
 
Recipient mice were lethally irradiated
(1150cGy 
 
  
 
radiation delivered from caesium source) on day 0.
On day 1, BM was extracted from the femurs of donor mice and
T cells were depleted by negative selection using anti-Thy1(T24)-
biotin and Streptavidin microbeads (Miltenyi Biotec). Separation
was performed on a MACS magnetic column (Miltenyi Biotec)
according to manufacturer’s instructions. 5 
 
  
 
10
 
6 
 
BM cells were
injected intravenously into the irradiated recipients. The chimeras
were used after 8 wk to allow complete reconstitution.
To construct BM chimeras in which gene expression was re-
stricted to defined cell populations, we had to completely replace
the host hematopoietic system with donor BM cells. To be cer-
tain that our method of constructing chimeras did not allow sig-
nificant outgrowth or retention of host cells, we tested fully allo-
geneic chimeras 8 wk after reconstitution. When BM from
BALB/c mice (H-2
 
d
 
) is transferred into lethally irradiated (1150
cGy) C57BL6 mice (H-2
 
b
 
), 
 
 
 
99% of peripheral B cells and DCs
are of donor origin as assessed by FACS
 
® 
 
staining with IA
 
d
 
-spe-
cific (MK-D6) and IA
 
b
 
-specific (AF6-120.1) antibodies (unpub-
lished data). In addition, essentially all DCs generated in vitro by
culture of BM cells from these chimeras in the presence of GM-
CSF are of the donor MHC haplotype (unpublished data).
To assess the differential function of molecules (e.g., CD40 or
MHC class II) that are expressed on both B cells and DCs, the
following mixed BM chimera system was used, with the result
that CD40 was expressed only on DCs and was lacking on B
cells. Irradiated (1150 cGy) C57Bl/6 or 
 
 
 
MT mice, carrying a
gene deletion of the 
 
  
 
heavy chain causing a block in B cell dif-
ferentiation (27), were reconstituted with BM from 
 
 
 
MT mice
(80%) and CD40
 
    
 
mice (20%). Thus, 80% of the hematopoietic
cells (except B cells) in the chimeric mice will be wild-type in
gene expression whereas the B cells can only be derived from
CD40
 
    
 
precursors. Over an 8-wk period, the 20% knockout
BM completely repopulated the peripheral lymphoid system with
B cells while contributing only 20% to other lineages. In this
way, we ensured that the function of DCs was minimally im-
paired whereas CD40 function in B cells was abolished. To en-
sure that all the B cells were CD40
 
   
 
, we stimulated purified B
cells from these chimeric mice with anti-CD40 and IL-4 and
measured proliferation. This assay, which detected 1% spiked
contamination of wild-type B cells in a CD40
 
    
 
spleen culture,
showed no proliferative response from these chimeras.
 
DCs and Macrophages.
 
DCs were derived from BM cells ac-
cording to the procedure developed by Inaba et al. (32). In brief,T
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BM cells were cultivated in RPMI plus 10% FCS supplemented
with GM-CSF (X63-GM-CSF–producing cell line supernatant;
reference 17). On the third day, nonadherent cells were washed
away and remaining cells were cultivated in RPMI 1.5% mouse
serum supplemented with GM-CSF. An additional wash was
performed on day 6. On day 7, the culture typically contained
 
 
 
90% pure BM-DCs. DCs were pulsed for 3–6 h with 300 
 
 
 
g/
ml DNP-KLH or 100 
 
 
 
g/ml KLH or OVA. 10
 
6 
 
cells were then
injected intravenously. In some experiments, mice received a
concurrent intraperitoneal injection of alum-precipitated antigen.
Splenic DCs were purified according to the protocol previ-
ously described (33). Contaminating B cells were depleted using
anti-CD19–coated Dynabeads (Dynal). This gave a preparation
containing 80–90% pure DCs.
Macrophages were derived by culturing BM cells in DMEM
plus 25% FCS, supplemented with 20% M-CSF–containing su-
pernatant (from the L929 cell line; ATCC). Nonadherent cells
were washed off the plates at days 4 and 6 and the macrophages
were harvested from the plates at day 7, pulsed with antigen, and
injected as described above for DCs.
 
OT-II T Cell Transfers.
 
2.5 
 
  
 
10
 
6 
 
lymph node cells from
OT-II TCR transgenic mice (H2-A
 
b
 
–restricted OVA peptide,
323–339-specific) backcrossed onto a CD40-deficient back-
ground representing 1.5 
 
  
 
10
 
6 
 
transgenic T cells were transferred
intravenously into nonirradiated recipient mice. After 24 h, the
mice were immunized with either 100 
 
 
 
g OVA peptide or 100
 
 
 
g KLH in CFA. Accumulation of cells in follicles or FACS
 
®
 
analysis was performed 4–6 d after immunization. OT-II TCR
transgenic T cells were recognized by their expression of V
 
 
 
5.
 
Immunohistology.
 
Spleens were harvested, embedded in
Cryo-M-Bed embedding compound (Bright Instrument Com-
pany Ltd.), and frozen at 
 
 
 
80
 
 
 
C. 5-
 
 
 
m thick frozen sections
were fixed on cold acetone and dried extensively. The sections
were stained with T24 (anti–Thy-1) for T cells and anti-IgD for
B cells (The Binding Site). Biotinylated anti–sheep/goat immu-
noglobulin was added 2 h later. Streptavidin–Texas Red (South-
ern Biotechnology Associates, Inc.) and FITC-conjugated (Fab’)
 
2
 
mouse anti–rat (Jackson ImmunoResearch Laboratories) were
added 1 h later.
 
Quantitative Histology.
 
B cell follicles were delineated in
splenic tissue sections by staining with anti-IgD. T cells were
identified as Thy1
 
  
 
cells. Slides were viewed on an Olympus
BX50 microscope under reflected light fluorescence. Images
were captured using a Hamamatsu digital camera and Openlab
image analysis software (Improvision). The number of T cells
within the IgD
 
  
 
area was counted. For each mouse in a group,
10–15 follicles were counted in this way. The area of the follicles
(in arbitrary units) was quantified using the Openlab program.
The number of B cells occupying any follicular area could be cal-
culated from this by extrapolation from previous counts of B cells
in defined follicular areas. The total follicular area counted in all
mice varied by 
 
 
 
5%. The number of follicular T cells was ex-
pressed per follicular section. In some analyses this was plotted
against the number of B cells within the follicular section or the
number of T cells in the adjacent T cell zone.
 
Results
 
T Cell Accumulation in B Cell Follicles Requires CD40 and
Is Proportional to Follicular Size.
 
The dynamics of T cell
accumulation in B cell follicles were assessed in normal
C57BL6 mice after immunization with DNP-OVA. The
number of T cells per follicle progressively increased from
around day 4 when it was first noticeable and peaking be-
tween days 6 and 12, with on average 63 T cells per follicle
(Fig. 1 A). As Fig. 1 shows, there is some variation around
the median number of T cells per follicle. To see if this
variation was related to the number of responding B cells,
space within the follicle, or the number of responding T
cells in the adjacent T zone, we measured the area of each
follicle counted and the area of the neighboring T zone. It
is clear from Fig. 2 that the number of follicular T cells is
Figure 1. Antigen-driven accumulation of T
cells in B cell follicles is dependent on CD40. (A)
The number of Thy1  T cells in follicles plotted
against time after immunization with alum-precipi-
tated DNP-OVA in normal C57Bl/6 mice ( ) or
CD40    mice ( ). Each point represents a count
from a single follicle. The bars show the median
values. The data is a compilation from three mice
in each group. This result is representative of four
such experiments. (B and C) Immunohistological
stain showing T cells in B cell follicles in C57Bl/6
(B) and CD40    mice (C) 6 d after immunization.
Note the relative lack of green Thy-1  cells in the
IgD  follicle of the CD40    mouse. (D) The num-
ber of OT-II TCR transgenic T cells (identified by
V 5 staining) in inguinal lymph node follicles in
normal (C57Bl/6) and CD40    mice 6 d after
immunization in the footpad with 100  g OVA
peptide (323–339) plus CFA.T
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proportional to the size of the follicles but not to the size of
the T zone. The presence of GCs in follicles made no dif-
ference to this analysis and conclusion. There is a remark-
ably stable ratio of 4 T cells to 100 B cells in the follicles.
This indicates an influence of the B cell compartment on
the accumulation of T cells in the follicle.
In contrast to normal C57BL6 mice, the number of folli-
cular T cells in CD40
 
    
 
mice was unchanged after immu-
nization (Fig. 1 B). We also observed no migration of T
cells to follicles in CD154
 
    
 
(CD40L
 
   
 
) mice after im-
munization (unpublished data). Therefore, the accumula-
tion of Th cells in B cell follicles that occurs after immuni-
zation is CD40 dependent. Follicles in nonimmunized
C57BL6 and CD40
 
    
 
mice contained an average of 25 T
cells. This constitutive, CD40-independent presence of
T cells in follicles may represent localization of memory T
cells or possibly the (CD1-restricted) NK1.1 CD4 T cells
seen in the follicles of MHC class II–deficient mice (24).
We confirmed that the migration of T cells to follicles was
antigen specific by transferring OT-II H2-A
 
b
 
–restricted,
OVA peptide–specific TCR transgenic T cells into normal
(B6) or CD40
 
    
 
mice and then immunizing with either
OVA or KLH. Fig. 1 D shows that OT-II localize to folli-
cles after OVA immunization in normal mice but to a
much lesser extent in CD40
 
    
 
mice. We were unable to
see any V
 
 
 
5
 
  
 
OT-II T cells in the follicles after transfer
when mice (normal or CD40-deficient) were immunized
with the irrelevant antigen, KLH (unpublished data).
 
Expression of CD40 Is Required on Hematopoietic Cells for T
Cell Accumulation in B Cell Follicles.
 
To determine the cell
type on which CD40 was required, we took the approach
of making mixed BM chimeras in which the expression of
CD40 could be restricted to defined populations of cells.
First, to validate this methodology, we performed C57Bl/6
BM 
 
→
 
 C57Bl/6 transfers and the resulting chimeras
showed normal T cell migration to follicles comparable
to nonmanipulated C57Bl/6 mice (Fig. 3 A), whereas
CD40
 
    
 
BM 
 
→ 
 
CD40
 
    
 
chimeras did not. Thus, the
process of irradiation and reconstitution did not impair
quantitatively or qualitatively the behavior of T cells.
To assess whether hematopoietic and/or non-BM-
derived stromal cells were necessary for T cell accumulation
in follicles, we made chimeras in which all the hematopoi-
 
etic cells were replaced with CD40-deficient BM (CD40
 
 
 
/
 
 
 
BM 
 
→ 
 
C57Bl/6). In such mice, radio-resistant stromal
cells (e.g., follicular DCs [FDCs]) in lymphoid tissues
would be CD40
 
  
 
whereas all BM-derived lineages would
be CD40
 
 
 
. FDCs express CD40 and produce chemokines
such as BLCs (CXCL13), which cause the migration of B
cells to follicles (10, 12). In these (CD40
 
    
 
BM 
 
→ 
 
C57Bl/6)
chimeras, T cells did not accumulate in follicles after im-
munization (Fig. 3 A). In contrast, C57Bl/6 BM 
 
→
 
CD40
 
    
 
chimeras, where all hematopoietic lineages were
CD40
 
  
 
but stroma was CD40
 
 
 
, exhibited normal T cell
migration to follicles. Taken together, these data demon-
strated a crucial role for CD40-expressing hematopoietic
cells in follicular migration of T cells. The obvious candi-
dates to investigate further were DCs and B cells.
 
Expression of CD40 on B Cells Is Not Required for T Cell
Accumulation in B Cell Follicles.
 
In the light of our previous
data on the influence of B cells on T cell differentiation (17)
and the observation that follicular T cell number was related
to follicular size (Fig. 2), we chose first to investigate the
possibility that B cells regulate T cell entry into follicles. To
test this hypothesis, we developed mixed BM chimeras in
which the CD40 deficiency was restricted to the B cell
compartment. Thus, chimeras were generated where all B
cells lack CD40 but the majority (80%) of the DCs are
CD40
 
 
 
. This was achieved by injecting a mixture of BM
from 
 
 
 
MT mice (80%) and CD40
 
    
 
mice (20%) into le-
thally irradiated (11.5Gy) C57BL6 mice. The 
 
 
 
MT BM
gives rise to no B cells and therefore all B cells in these chi-
meras were derived from CD40
 
     hematopoietic stem
cells. The other hematopoietic cell types were mostly de-
rived from the  MT BM as it made up 80% of the BM in-
oculum and were therefore wild type with respect to CD40.
There was a complete replacement of the host B cell system
in these chimeras and any residual host (CD40 ) B cell con-
tamination was significantly  1%. In these chimeras, T cells
accumulated normally in B cell follicles after immunization
(Fig. 3 B). Therefore, expression of CD40 on B cells is not
required for the migration. No IgG response or GC forma-
tion was seen in these chimeras (unpublished data).
Antigen Presentation by B Cells Is Not Required for T Cell
Accumulation in B Cell Follicles. Although the previous ex-
periment excludes a role for CD40 on B cells, their presen-
Figure 2. T cell accumulation in B cell follicles is
correlated with the follicular size. Spleens from C57Bl6
mice were collected 6 d after immunization with alum-
precipitated DNP-KLH intraperitoneally. Each point
represents a single follicle. The data are a compilation
of counts of T cells in splenic follicles from three mice.
The result is representative of two such experiments.
(A) The number of Thy-1  T cells present in a follicle
is proportional to the size of the follicle (P   0.001, us-
ing Pearson correlation coefficient). (B) There is no
correlation between the number of follicular Thy-1 
cells and the size of the adjacent T cell area.T
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tation of MHC class II–peptide complexes during a T–B
interaction might still be important. This was tested directly
by constructing chimeras in which DCs (and macrophages)
express MHC class II but B cells do not. Thus, we injected
a mixture of  MT (80%) and A     (20%) BM into le-
thally irradiated  MT recipients. In these chimeras, B cells
can capture and process the antigen but they are unable to
present it to Th cells (although T cells can be activated by
DCs). Fig. 4 A shows that Th cells accumulated in B cell
follicles in normal numbers in these mice. Therefore, cog-
nate interaction between B and T cells is not required for T
cell accumulation in B cell follicles. Additional experiments
showed that follicular localization of T cells occurred in the
absence of any B cell activation. Thus, in BM chimeras
( MT   MD4-RAG BM →  MT) in which all the B
cells are hen egg lysozyme (HEL)-specific (on RAG1   
background), immunization with KLH provoked normal T
cell migration to follicles (unpublished data).
Expression of CD40 on DCs Is Necessary for T Cell Accu-
mulation in B Cell Follicles. If B cells do not control migra-
tion, the next likely candidates are DCs. Indeed, mixed
BM chimeras in which CD40 expression was restricted
to non-B, nonstromal cells ( MT     CD40    BM  →
CD40   ) exhibited normal follicular migration of T cells
(Fig. 3 B), implicating myeloid cells including DCs. Using
BM chimeras to restrict the effects of a gene knockout to
the DC population was not possible in the absence of a
mouse line that specifically lacks DCs. Therefore, we asked
directly if expression of CD40 on DCs was sufficient to
promote T cell migration to B cell follicles. This was done
by injecting CD40-deficient mice with antigen-pulsed
DCs generated from CD40  or CD40  BM (by growth in
Figure 3. Cell interactions involved inCD40-dependent accumulation
of T cells in B cell follicles. Chimeras were immunized with alum-precip-
itated DNP-KLH intraperitoneally 8 wk after reconstitution with BM
cells. Spleens were collected 6 d after immunization. (A) Follicular T cell
localization requires CD40 on hematopoietic cells. (B) Follicular T cell
localization does not require CD40 on B cells. The data were plotted us-
ing a box and whiskers representation. The box extends from the 25th to
the 75th percentile, with a horizontal line at the median (50th percentile).
Whiskers extend down to the smallest value and up to the largest. The
data are a compilation of counts of T cells in splenic follicles from three
mice. These results (A and B) are representative of three such experi-
ments. Donor BM is shown to the left of the arrow and the irradiated re-
cipient to the right. CD40 phenotype of DCs, B cells, and radio-resistant
stromal cells (Str) in each chimera is shown.
Figure 4. T cell accumulation in lymphoid follicles does not require
MHC class II nor CD40L expression by B cells. (A) Follicular T cell lo-
calization in chimeras lacking MHC class II on B cells ( MT [80%]  
IA  /  [20%] →  MT). (B) Follicular accumulation of T cells requires
CD40L expression by T cells but not B cells. The CD40L phenotype of
DCs, T cells, and B cells in each chimera is shown. Chimeras were immu-
nized intraperitoneally with alum-precipitated DNP-KLH 8 wk after re-
constitution with BM cells. Spleens were collected 6 (B) or 10 d (A) after
immunization. The data are a compilation of counts of T cells in splenic
follicles from three (A) or four mice (B), analyzed as described in Fig. 3.
The result is representative from three such experiments.T
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GM-CSF cultures). T cell localization in follicles was rap-
idly restored by CD40  but not by CD40    DCs (Fig. 5).
DCs (CD8  ) purified from the spleen were also potent
inducers of follicular T cell migration in CD40    mice
(unpublished data). It is possible that macrophages could
also cause T cell accumulation in follicles. To test this, we
derived macrophages from cultures of BM cells grown for
7 d in M-CSF. Upon antigen pulsing and transfer to
CD40    mice, these macrophages were unable to recon-
stitute follicular T cell migration (Fig. 5 A).
CD40L Is Required on T Cells for Them to Accumulate in
the Follicles. The results so far suggest that T cell accumu-
lation in the follicles depends on a CD40-dependent matu-
ration of DCs. To learn more of this maturation, we inves-
tigated which cell type delivered CD40L to the DC. T cells
(34, 35), B cells (36), and DCs (37) have all been shown to
express CD40. Delivery of a signal from the CD40L ex-
pressed by B cells (36) might explain the selective nature of
the migration. To dissect this, we constructed chimeras
where expression of CD40L was restricted to the DC by
injecting a mixture of BM from RAG1    (80%) and
CD40L    (20%) mice into CD40L    mice (RAG1  
CD40L    → CD40L   ). In these mice, all lymphocytes
are derived from CD40L   -deficient BM whereas DCs
are derived mainly from RAG    BM. We also constructed
chimeras in which DCs and T cells, but not B cells, ex-
pressed CD40L ( MT   CD40L    → CD40L   ) and
chimeras in which DCs, T cells, and B cells expressed
CD40L ( MT   C57BL6 → CD40L / ). Fig. 4 B shows
that T cell migration occurs when both T cells and DCs
express CD40L. Because expression of CD40L by DCs
alone is not sufficient (Fig. 4 B), we infer that CD40L sig-
nals are delivered by T cells to DCs.
T Cell Migration into B Cell Follicles Requires CD40 Activa-
tion and Cannot Be Elicited by LPS, CpG DNA, or B. per-
tussis. We wished to know whether other activators of
DCs (38), in particular those derived from microorganisms,
could replace the CD40 signal to allow follicular T cell mi-
gration in CD40 /  mice. CD40 /  mice were immunized
with DNP-KLH together with LPS, CpG DNA, or chem-
ically killed B. pertussis. None of these adjuvants would
permit T cell accumulation in the follicles at days 5 or 9
(Fig. 6). In contrast, injection of a stimulating anti-CD40
antibody (FGK-45) into CD40L    mice restored T cell
migration to follicles (Fig. 6).
T Cell Accumulation in B Cell Follicles Is Dependent on
OX-40 Signals. OX40 signals have been implicated in the
migration of T cells to follicles (14, 15, 39). We investi-
gated whether the CD40-dependent event on DCs was the
up-regulation of OX40L. As shown in Fig. 7 A, OX40L
was most efficiently induced on DCs by anti-CD40. LPS
had no effect and CpG DNA only had a marginal one (Fig.
7 A). In B cells, OX40L was also only up-regulated in the
presence of CD40 signals (unpublished data). To see if a
lack of OX40L expression could be a major cause of the
migration defect in CD40    mice, we treated them with
OX40L–huIgG1 fusion protein. An agonistic costimula-
tory role for this fusion protein has previously been shown
(31). Fig. 7 B shows that OX40L–huIgG1 restored T cell
migration to follicles when injected into CD40    mice
whereas B7.1–huIgG1 did not. This data, taken in con-
junction with the conclusion that CD40-expressing DCs
are necessary for follicular T cell migration, implies that up-
regulation of OX40L on DCs is the inductive event. We
confirmed the role of OX40 in follicular migration of T
cells by analyzing their accumulation after the immuniza-
Figure 5. T cells accumulate in B cell follicles of
CD40    mice immunized with CD40  DCs. (A)
CD40    and C57Bl6 mice were immunized by in-
travenous injection of 106 CD40  (light gray boxes)
or CD40-, BM-derived DCs (white box) or mac-
rophages (dark gray box) pulsed with DNP-KLH.
Spleens were collected 4 d after immunization. The
data are a compilation of counts of T cells in splenic
follicles from three mice, analyzed as described in
Fig. 3. (B and C) Immunohistological stain show-
ing T cells in B cell follicles in CD40    mice immu-
nized with CD40    (B) and CD40  DCs (C).
Note the relative lack of green Thy-1  cells in the
IgD  follicle of the CD40    mouse immunized
with CD40    DCs. This experiment was repeated
three times with similar results.T
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tion of OX40 knockout mice. As shown in Fig. 7 C, the
OX40-deficient mice show little antigen-driven accumula-
tion of T cells in follicles.
CXCR5 Induction on Naive T Cells Is Antigen Specific
and Impaired in CD40-deficient Mice. To see if CXCR5
induction on T cells in vivo is an antigen-driven,
CD40-dependent event, we transferred 2.5   106 OT-II
T cells (from H2-Ab–restricted, OVA peptide–specific
TCR transgenic mice, backcrossed to a CD40-deficient
background) into normal and CD40 knockout mice and
immunized them with OVA or KLH (in CFA). We could
see up-regulation of CXCR5 on the majority (66%) of
V 5 (OT-II   chain)-expressing T cells in OVA-immunized
normal mice, but relatively few (19%) in KLH-immu-
nized mice (Fig. 7 D). The up-regulation of CXCR5 ex-
pression on antigen-activated T cells in CD40    mice was
impaired despite blasting, proliferation, and up-regulation
of CD44 (unpublished data).
Discussion
The migration of T cells into B cell follicles is a selective
process as only a fraction of the T cells activated in the first
days after immunization have the capacity to localize here.
T cells are required in follicles to provide help for the de-
velopment of high affinity antibodies and memory B cells.
However, the transfer of information between T and B
cells is not unidirectional as B cells also influence T cell dif-
ferentiation by eliciting Th2 responses advantageous to the
B cells (17, 40–42). For these reasons it seemed likely that
B cells would regulate the process of migration and entry
into follicles. However, the evidence presented here shows
Figure 6. T cell accumulation in B cell folli-
cles requires a CD40 signal, which cannot be
substituted by microorganism-derived activators
of DCs. CD40 /  mice were immunized intra-
peritoneally with alum-precipitated DNP-KLH
together with one of the following products:
chemically killed B. pertussis, LPS, or CpG, all
at the doses indicated in Materials and Methods.
CD40L    mice were injected once with 200
 g FGK-45 intravenously 6 h after immuniza-
tion with alum-precipitated DNP-KLH. The
data are a compilation of counts of T cells in
splenic follicles from three mice, analyzed as de-
scribed in Fig. 3. This result is representative of
two similar experiments.
Figure 7. The role of OX40L on DCs and B
cells in follicular migration of T cells. (A) Ex-
pression of OX40L on purified splenic DCs
stimulated for 48 h with FGK-45 (anti-CD40),
LPS, CpG DNA, and non-CpG DNA (as indi-
cated). Data were collected and analyzed on a
FACScalibur®  using CELLQuest™ software.
Dead cells are excluded using 7AAD. DCs were
gated on CD11c  cells. The dotted line shows
the staining profile of isotype-matched controls.
(B) T cell migration to follicles is reconstituted
in CD40     mice by injection of OX40L–
huIgG1. Mice were immunized intraperito-
neally with alum-precipitated DNP-KLH and
then injected daily intravenously from days 1 to
5 with 200  g B7–huIgG1 or OX40L–huIgG1.
Spleens were collected at day 6. This result is
representative of two similar experiments. (C)
T cell migration to follicles is impaired in
OX40-deficient mice. Spleens were taken from
knockout and control mice (five of each) 8 d af-
ter immunization. The data are a compilation of
counts of T cells in splenic follicles from three
to five mice and analyzed as described in Fig. 3.
(D) Up-regulation of CXCR5 on T cells is an-
tigen specific and CD40 dependent. FACS® plots of CXCR-5 expression on OVA-specific OT-II (V 5 ) CD4  T cells after transfer into normal (filled
profile) and CD40 /  mice (solid line) after immunization with OVA (323–339) peptide or normal mice immunized with KLH. Data is representative of
two experiments.T
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that B cells do not direct T cell migration in any immediate
or obvious way. Rather, T cell migration to follicles is con-
trolled by DCs.
Our initial observation was that T cells do not accumu-
late in the follicles of CD40-deficient mice. Restoration of
CD40 expression on DCs is sufficient to reinstate T cell
localization. Furthermore, a selective absence of CD40 on
B cells (in BM chimeras) had no effect on follicular migra-
tion of T cells. Interestingly, T cell activation in these chi-
meras (in which CD40 on DCs was normal) is unim-
paired. Proliferative responses and cytokine production are
similar to T cells from control chimeras when isolated 10 d
after immunization and restimulated in vitro (unpublished
data). Thus, B cells that lack CD40 are not inherently
tolerogenic as reported previously for allogeneic responses
(43, 44). Cognate interaction between B and T cells,
thought to occur at the margins of the follicles, is also dis-
pensable as T cells migrated to follicles in chimeras in
which B cells expressed no MHC class II (DCs in these
mice were MHC class II ). Therefore, B–T cell contact
involving antigen presentation and CD40 ligation is un-
necessary for T cell migration to follicles. Another possible
means of B cell action is through the release of chemo-
kines or cytokines after BCR cross-linking with antigen.
These could initiate T cell migration directly or induce the
up-regulation of receptors that would allow T cells to re-
spond to a chemotactic gradient originating from the folli-
cular stromal cells (e.g., BLC; references 10 and 11). How-
ever, in chimeras ( MT    MD4-RAG BM →  MT)
where there is no possibility of B cell activation via the
BCR, T cells still migrated to follicles. Thus, the chemo-
kines made by activated B cells, ABCD-1, ABCD-2 (20),
fractalkine (21), IL-16 (18), MIP-1 , and MIP-1  (19) do
not seem to be required to attract T cells to follicles. How-
ever, they might be important at a later stage to bring fol-
licular T cells into GCs.
The observation that activated B cells do not attract T
cells to lymphoid follicles suggests to us that the migration
of T cells to the follicles is not solely for the purpose of
helping B cells, but also for reasons related to normal T cell
differentiation pathways. For instance, the interactions that
occur in the follicle may optimize clonal expansion of T
cells. There is evidence that the follicle is a major site of
CD4 T cell proliferation (45, 46). It is also intriguing that
Fas-expressing activated B cells can protect activated T
cells from activation-induced cell death (47). In vivo this is
likely to occur in the B cell follicle. Survival of cells after
activation-induced cell death is likely to be related to the
formation of the memory pool and the action of B cells as
Fas decoys might be the basis of their role in the develop-
ment or maintenance of CD4 T cell memory that we (48)
and others (49) have shown. It may not be coincidence
that markers that distinguish various memory T cell sub-
sets, e.g., the chemokine receptors CCR7 and CXCR-5
(3–5, 50–52), are important for the positioning of T cells
in or out of the lymphoid follicles, suggesting a link be-
tween passage through the follicle and differentiation into
these subsets.
The strong correlation of the number of T cells accumu-
lating in B cell follicles with the size of the follicle might be
related to the B cell control of events within the follicle as
discussed above. At the peak of the response, we could de-
tect 4 T cells per 100 B cells in the follicle, whether the B
cells were responding to antigen or not (e.g., in  MT  
MD4-RAG BM →  MT chimeras). This indicates that
the process of accumulation in the follicle is limited by fac-
tors present in follicles and is unrelated to the scale of T cell
activation in the T zone. Such factors might be constitu-
tively delivered by B cells, follicular stroma cells such as
FDCs, or DCs present within the follicle. They could act
by regulating T cell proliferation, survival, entry, or exit
from the follicle.
Our data demonstrate that DCs control the initial migra-
tion of T cells into follicles. T cell migration was restored
in CD40     mice when they were immunized with
CD40  DCs. In addition, because treatment of CD40L   
mice with a stimulating anti-CD40 antibody allowed T
cell migration to occur, the important step is the matura-
tion of the DCs induced via CD40. It is important to note
that T cell migration could not be reinstated in CD40-
deficient mice by immunizing with products derived from
microorganisms, which are known activators of DCs (e.g.,
LPS and CpG). This result emphasizes the importance of
CD40 in the development of helper function. In the ab-
sence of CD40-dependent maturation, DCs prime CD4 
T cells as demonstrated by the normal clonal expansion and
T-dependent IgM response in CD40    mice (40), but
these primed T cells fail to develop effector functions.
They do not accumulate in B cell follicles and do not de-
velop helper function to support GC formation or an IgG
response by adoptively transferred wild-type B cells (40
and unpublished data). However, both GCs and IgG are
restored when wild-type splenocytes (including DCs and B
cells) are transferred into CD40     mice (unpublished
data). Similarly, the generation of CTLs also requires a
CD40-dependent maturation of DCs that cannot be
achieved by LPS (53).
The CD40-dependent maturation of DCs required for T
cells to accumulate in B cell follicles seems to consist of the
acquisition of specific costimulatory capacity, as it can be
overcome by the injection of OX40L–huIgG1 (but not
B7.1–huIgG1) into CD40    mice. The crucial role of
OX-40 is confirmed, as OX40-deficient mice show essen-
tially the same defect in follicular T cell accumulation as
CD40    mice. As we also show that up-regulation of
CXCR-5 on activated T cells is impaired in CD40   
mice, we surmise that CD40 signals to DCs induce
OX40L, which in turn stimulates CXCR-5 expression by
T cells. Our results are in agreement with those of Flynn et
al. (14) and Brocker et al. (15) who have shown that stimu-
lation of T cells via OX40L resulted in CXCR-5 expres-
sion in vitro (14) and increased accumulation of T cells into
the follicles in vivo (15). The expression of OX40L on the
DC, in turn ligating OX40 on the T cell, profoundly
changes its migratory behavior. Interestingly, neither LPS
nor CpG could induce OX40L expression on purifiedT
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splenic DCs or B cells. Being strictly dependent upon
CD40 stimulation, OX40L expression by DCs appears to
be a specific signature of the cognate interaction with T
cells and is not associated with “innate” activation. Our re-
sults support a sequential model of T cell activation where
DCs first prime T cells and induce CD40L up-regulation,
which in turn stimulates the DC via CD40. This induces
the up-regulation of “late” costimulatory molecules such as
OX40L that regulate T cell differentiation (14, 54), migra-
tory properties via CXCR-5 (14, 15), and survival by pro-
moting Bcl-xL and Bcl-2 expression (55). Many of the
other effects of CD40 ligation on DCs, such as up-regula-
tion of IL-12p70 (56), antigen loading onto MHC class II
(57), expression of MHC class II (58), costimulatory mole-
cules CD80 (B7-1) and CD86 (B7-2; references 59 and
60), and enhanced DC survival (58, 61) can also be
achieved by signals such as LPS and CpG.
The impairment of T cell responses in OX40- and
OX40L-deficient mice (28, 62, 63, 64) may well relate to
secondary effects absent due to the suboptimal B–T cell in-
teraction in follicles that we demonstrate here. OX40 has
been shown to be necessary for long-term CD4 T cell sur-
vival and memory (55) and it remains to be seen if this a
wholly direct effect or if it is a correlate of impaired migra-
tion to follicles and the subsequent events in that site. De-
spite minimal T cell migration to follicles in OX40    mice
have a normal GC response and normal T-dependent anti-
body responses, which may mean that T–B cell interactions
in follicles are not crucial for these responses. Certainly, we
believe that the induction of a costimulatory molecule,
other than OX40, on DCs or B cells by CD40 ligation is
important for these.
Our results do not explain the selectivity of the migra-
tion process. Not all activated T cells enter B cell follicles
(65). We assume that CXCR-5 is involved in this migra-
tion, although there is no definitive proof of this. In human
tonsils, CXCR-5 was found on  90% of memory type
CD4 T cells (5), however, not all of these inhabit follicles.
Levels of CCR7 expression might be an important parame-
ter as movement of activated T cells to the follicles seems
to require CCR7 down-regulation (66). Maintenance of
CCR7 expression may override CXCR-5–mediated BLC
chemoattraction and retain activated T cells within the T
cell area, a notion supported by the observation that
CXCR-5  CD57  T cells, which are only located in GCs,
have completely lost CCR7 expression and Epstein Barr
Virus–induced molecule 1 ligand chemokine (ELC)/
CCL19 responsiveness (5). In contrast, CXCR-5  CD57 
T cells, found in the follicles and at the border between the
T zone and the follicle, still respond to ELC as a population
and some of them express CCR7 (5). Similarly, B cell fol-
licular exclusion of antigen-stimulated (9, 67) or anergic B
cells (67, 68) is not associated with a decreased BLC re-
sponsiveness (69). The follicular exclusion of these cells
correlates with an increased responsiveness to T zone che-
mokines ELC and secondary lymphoid chemokine (SLC)/
CCL21 (69, 70). It seems likely, based on the recent work
of Reif et al. (71) that T cells, in the same way as B cells,
are responding to opposing gradients of SLC/ELC gener-
ated by T zone DCs on the one hand and BLC from follic-
ular stroma on the other. CCR7 persistence on some acti-
vated T cells could be due to priming by different DC
subsets or signal strength (72). It is conceivable that the ba-
sis of selective follicular migration lies in the heterogeneity
and position of DC subsets, programming T cell differenti-
ation (and migration) in a step-wise fashion.
In conclusion, the following intriguing issues await res-
olution: (a) the basis of selective regulation of follicular
migration, whether differential responsiveness to gradients
of two or more chemokines or the involvement of differ-
ent subsets of DCs, (b) the control of migration and differ-
entiation of T cells within the follicle (e.g., into GCs), and
(c) the identity of the factors controlling the follicular T
cell pool size. Although we have gone some way to an-
swer the question of how T cells migrate to follicles, it is
important that we not forget to ask why. Providing help
for B cells is only part of the story and delving further may
reveal the influences of B cells on T cell differentiation and
memory generation.
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